Key factors in children’s competence to consent to clinical research
Open Access
- 24 October 2015
- journal article
- research article
- Published by Springer Nature in BMC Medical Ethics
- Vol. 16 (1) , 1-6
Abstract
Although law is established on a strong presumption that persons younger than a certain age are not competent to consent, statutory age limits for asking children’s consent to clinical research differ widely internationally. From a clinical perspective, competence is assumed to involve many factors including the developmental stage, the influence of parents and peers, and life experience. We examined potential determining factors for children’s competence to consent to clinical research and to what extent they explain the variation in competence judgments. From January 1, 2012 through January 1, 2014, pediatric patients aged 6 to 18 years, eligible for clinical research studies were enrolled prospectively at various in- and outpatient pediatric departments. Children’s competence to consent was assessed by MacArthur Competence Assessment Tool for Clinical Research. Potential determining child variables included age, gender, intelligence, disease experience, ethnicity and socio-economic status (SES). We used logistic regression analysis and change in explained variance in competence judgments to quantify the contribution of a child variable to the total explained variance. Contextual factors included risk and complexity of the decision to participate, parental competence judgment and the child’s or parents decision to participate. Out of 209 eligible patients, 161 were included (mean age, 10.6 years, 47.2 % male). Age, SES, intelligence, ethnicity, complexity, parental competence judgment and trial participation were univariately associated with competence (P < 0.05). Total explained variance in competence judgments was 71.5 %. Only age and intelligence significantly and independently explained the variance in competence judgments, explaining 56.6 % and 12.7 % of the total variance respectively. SES, male gender, disease experience and ethnicity each explained less than 1 % of the variance in competence judgments. Contextual factors together explained an extra 2.8 % (P > 0.05). Age is the factor that explaines most of to the variance in children’s competence to consent, followed by intelligence. Experience with disease did not affect competence in this study, nor did other variables. Development and use of a standardized instrument for assessing children’s competence to consent in drug trials: Are legally established age limits valid?, NTR3918 .Keywords
This publication has 16 references indexed in Scilit:
- Assessing children’s competence to consent in research by a standardized tool: a validity studyBMC Pediatrics, 2012
- How should paediatricians assess Gillick competence?Archives of Disease in Childhood, 2009
- A review of children’s decision‐making competence in health careJournal of Clinical Nursing, 2008
- Identity Development, Coping, and Adjustment in Emerging Adults With a Chronic Illness: The Sample Case of Type 1 DiabetesJournal of Adolescent Health, 2008
- Treatment Outcome Studies With Children: Principles of Proper PracticeEthics & Behavior, 2008
- Competent children? Minors’ consent to health care treatment and researchSocial Science & Medicine, 2007
- Ethical Issues in Adolescent and Parent Informed Consent for Pediatric Asthma Research ParticipationJournal of Asthma, 2007
- Assent in paediatric research: theoretical and practical considerations: Figure 1Journal of Medical Ethics, 2006
- Children's Competence for Assent and Consent: A Review of Empirical FindingsEthics & Behavior, 2004
- Assessing Patients' Capacities to Consent to TreatmentNew England Journal of Medicine, 1988